Francesca Borgna
Villigen, AG, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Targeted β--Particle Plus Conversion and Auger-Electron Therapy with 161Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 17, 2025
Design and Preclinical Evaluation of a Novel Prostate-Specific Membrane Antigen Radioligand Modified with a Transthyretin Binder.
Journal: Cancers
Published: February 16, 2024
First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 21, 2023
Preclinical Investigations to Explore the Difference between the Diastereomers [177Lu]Lu-SibuDAB and [177Lu]Lu-RibuDAB toward Prostate Cancer Therapy.
Journal: Molecular pharmaceutics
Published: May 11, 2022
Preclinical investigations using [177Lu]Lu-Ibu-DAB-PSMA toward its clinical translation for radioligand therapy of prostate cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: November 06, 2021
Cyclotron production and radiochemical purification of terbium-155 for SPECT imaging.
Journal: EJNMMI radiopharmacy and chemistry
Published: August 05, 2021
Combination of terbium-161 with somatostatin receptor antagonists-a potential paradigm shift for the treatment of neuroendocrine neoplasms.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 21, 2021
Impact of the mouse model and molar amount of injected ligand on the tissue distribution profile of PSMA radioligands.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 19, 2021
Development of implantation substrates for the collection of radionuclides of medical interest produced via ISOL technique at INFN-LNL.
Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
Published: January 22, 2021
Preliminary Study of a 1,5-Benzodiazepine-Derivative Labelled with Indium-111 for CCK-2 Receptor Targeting.
Journal: Molecules (Basel, Switzerland)
Published: December 30, 2020
Production of Mass-Separated Erbium-169 Towards the First Preclinical in vitro Investigations.
Journal: Frontiers in medicine
Published: December 17, 2020
Last Updated: 09/26/2026